Home › Kidney Cancer › NCT02087852
Kidney Cancer DNA Registry
RecruitingObservational studyHealthy volunteers welcome
Who can join
Ages 18 and older · All sexes · Healthy volunteers welcome
Full eligibility criteria
Inclusion Criteria: Kidney Cancer Case Cohort: * Must be ≥ 18 years of age AND * Must be an English-speaker AND * Must have a diagnosis or suspicion of kidney cancer Family Member Cohort: * Must be ≥ 18 years of age AND * Must be an English-speaker AND * Must be a blood relative of the proband. Family members of probands including mother, father, sisters, brothers, half-sisters, half-brothers, daughters, sons, grandmothers, grandfathers, as well as aunts and uncles are eligible. These individuals need not have kidney cancer, as they will be used for segregation analysis of suspected variants found in the proband; requesting DNA from relatives is required. Control Cohort: * Must be ≥ 18 years of age AND * Must be an English-speaker AND * Must not have a personal history of cancer, with the exception of nonmelanoma skin cancer, AND * Must not be a blood relative of any cases or controls enrolled in this study Exclusion Criteria: * Patients who, in the opinion of the primary MSKCC clinician or the investigator, have a condition that precludes their ability to provide an informed consent
About the study
This registry will help us develop better methods of:
* Preventing these cancers * Diagnosing these cancers * Treating these cancers
What is being tested
- salvia for germline DNA (other)
- the Kidney Cancer Questionnaire (behavioral)
- Family History Questionnaire (when applicable) (behavioral)
- Blood draw (other)
- Epidemiologic Questionnaire (behavioral)
Sponsor: Memorial Sloan Kettering Cancer Center · Participants: 750 · Started: 2014-03
Contact the study team
- Jonathan Coleman, MD · Phone: 646-422-4432
- Kenneth Offit, MD · Phone: 646-888-4050
Official record on ClinicalTrials.gov — NCT02087852
Locations in the U.S.
Conditions
From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.